Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2078476824827835e-11,8.902178297700686,218.42756676606353,"['RPL41', 'RPL34', 'RPS3A', 'RPL23A', 'RPL10A', 'RPL9', 'RPS26', 'RPL7A', 'RPS15A', 'RPS27', 'RPS18', 'RPL27A', 'RPL37A', 'RPL26', 'FAU', 'RPS27A', 'RPS10', 'RPL17', 'RPS12']",7.771623842339398e-09,0,0,19
2,Vitamin D Receptor Pathway WP2877,8.02788589109931e-08,8.04340425531915,131.41120450171888,"['CDKN1A', 'SERPINB1', 'GADD45A', 'HILPDA', 'TNFRSF11B', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'S100A6', 'CD9', 'PRKCQ', 'JUNB']",1.4129079168334785e-05,0,0,13
3,Adipogenesis WP236,6.786813976370771e-05,4.692460317460317,45.03797067555442,"['SOCS3', 'CDKN1A', 'CEBPB', 'KLF6', 'GADD45B', 'CEBPD', 'GADD45A', 'NAMPT', 'PNPLA3', 'ID3', 'IRS2']",0.00796319506560837,0,0,11
4,Complement and Coagulation Cascades WP558,0.0001521253869266459,12.662760416666666,111.31586344979121,"['CPB2', 'C1R', 'PROS1', 'SERPING1', 'F3']",0.01338703404954484,0,0,5
5,Differentiation of white and brown adipocyte WP2895,0.0002927294326003981,17.32838589981447,140.98828449150017,"['SMAD1', 'CEBPB', 'SMAD9', 'SLC7A10']",0.014990370115891665,0,0,4
6,Genotoxicity pathway WP4286,0.0002981039511683002,6.277794887588543,50.96356768880093,"['ACTA2', 'ITPKC', 'CDKN1A', 'RPS27', 'CEBPD', 'GADD45A', 'TRIM22']",0.014990370115891665,0,0,7
7,"GPCRs, Class A Rhodopsin-like WP455",0.0002981039511683002,6.277794887588543,50.96356768880093,"['P2RY12', 'OXTR', 'EDNRA', 'P2RY14', 'GPR87', 'GPR171', 'ACKR4']",0.014990370115891665,0,0,7
8,Spinal Cord Injury WP2431,0.0003500170796897134,4.587631578947368,36.50620952123483,"['LGALS3', 'ZFP36', 'VCAN', 'IL1R1', 'COL4A1', 'GADD45A', 'PLA2G5', 'ICAM1', 'GFAP']",0.01540075150634739,0,0,9
9,Type II interferon signaling (IFNG) WP619,0.000449754254694049,9.493815104166666,73.16702182568302,"['SOCS3', 'CIITA', 'GBP1', 'ICAM1', 'PSMB9']",0.01699811729226808,0,0,5
10,Osteoblast differentiation WP4787,0.00048290105943943405,4.368045112781955,33.353076700113014,"['HES6', 'SMAD1', 'FZD4', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'PRKCQ', 'FGFR3']",0.01699811729226808,0,0,9
11,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.0005386771824201604,5.615045467070819,42.261044995546555,"['CDKN1A', 'CEBPB', 'CEBPD', 'WNT7B', 'TNFRSF11B', 'JUNB', 'HES5']",0.01723766983744513,0,0,7
12,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0016481310794928593,18.15077720207254,116.3122370141187,"['CDKN1A', 'FAM20C', 'FGFR3']",0.048345178331790535,0,0,3
13,Globo Sphingolipid Metabolism WP1424,0.00181068442263017,9.325874125874126,58.88403898558017,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'A4GALT']",0.04902776282813998,0,0,4
14,Differentiation Pathway WP2848,0.0022694252409774835,8.658998144712431,52.7179608218113,"['NT5E', 'EGF', 'HGF', 'WNT7B']",0.053094097536133825,0,0,4
15,IL-4 signaling pathway WP395,0.0023942955029725445,4.930491849551902,29.75387273395454,"['SOCS3', 'CEBPB', 'NFIL3', 'SHC1', 'PIK3CD', 'IRS2']",0.053094097536133825,0,0,6
16,IL1 and megakaryocytes in obesity WP2865,0.002413368069824265,15.124352331606218,91.15041768889876,"['IL1R1', 'IL18', 'ICAM1']",0.053094097536133825,0,0,3
17,Apoptosis Modulation and Signaling WP1772,0.0033336553532652266,3.945898778359511,22.506167119769323,"['IL1R1', 'BAG3', 'TNFRSF10B', 'TNFRSF11B', 'MAP3K14', 'TNFRSF1A', 'HSPA1A']",0.06678107617655854,0,0,7
18,Vitamin B12 metabolism WP1533,0.003414941395392198,7.5753246753246755,43.024775748206615,"['SERPINA3', 'SOD2', 'LDLR', 'ICAM1']",0.06678107617655854,0,0,4
19,DNA damage response (only ATM dependent) WP710,0.0038363357015381325,3.4338102103434256,19.10310211586994,"['CDKN1A', 'BCL6', 'SHC1', 'WNT7B', 'PIK3CD', 'WNT7A', 'SOD2', 'LDLR']",0.06751950834707114,0,0,8
20,ESC Pluripotency Pathways WP3931,0.0038363357015381325,3.4338102103434256,19.10310211586994,"['SMAD1', 'FZD4', 'EGF', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'FGFR3']",0.06751950834707114,0,0,8
21,Hematopoietic Stem Cell Differentiation WP2849,0.00490060477983715,6.732467532467532,35.8059328182058,"['HES6', 'CIITA', 'PIM1', 'RUNX1']",0.0784096764773944,0,0,4
22,Lung fibrosis WP3624,0.00490060477983715,6.732467532467532,35.8059328182058,"['CEBPB', 'EGF', 'HGF', 'ATP11A']",0.0784096764773944,0,0,4
23,Breast cancer pathway WP4262,0.005954978422718964,2.9197088465845464,14.959209150156553,"['CDKN1A', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'PIK3CD', 'WNT7A', 'HES5']",0.09113706107813371,0,0,9
24,Oncostatin M Signaling Pathway WP2374,0.006888831598504477,3.87811788233987,19.304703789574116,"['SOCS3', 'CEBPB', 'SHC1', 'OSMR', 'JUNB', 'LDLR']",0.10103619677806565,0,0,6
25,Transcription factor regulation in adipogenesis WP3599,0.007465262143698556,9.071502590673575,44.427636151307354,"['CEBPB', 'CEBPD', 'IRS2']",0.10511089098327567,0,0,3
26,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.009710648072331098,20.11886304909561,93.24151975774708,"['SMAD1', 'SMAD9']",0.13146723544079025,0,0,2
27,Endometrial cancer WP4155,0.010623731948548567,3.503715605543282,15.92321339275434,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'FGFR3']",0.1385019868847813,0,0,6
28,VEGFA-VEGFR2 Signaling Pathway WP3888,0.01174658309679674,1.824644359203236,8.109071471446057,"['SHC1', 'HSPB1', 'PLA2G5', 'RPL10A', 'BMX', 'SOD2', 'SHB', 'NDRG1', 'F3', 'RAB11A', 'APOLD1', 'ICAM1', 'P4HA2', 'ADAMTS1', 'TMSB4X', 'TXNIP', 'MYH9', 'RPL26', 'TMSB10', 'HSPA1A']",0.1398976893216804,0,0,20
29,Folate Metabolism WP176,0.011787141679725877,5.046753246753247,22.411349443955977,"['SERPINA3', 'SOD2', 'LDLR', 'ICAM1']",0.1398976893216804,0,0,4
30,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.011923098521734126,3.989857456140351,17.672186688682928,"['SOCS3', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'YBX3']",0.1398976893216804,0,0,5
31,Transcriptional cascade regulating adipogenesis WP4211,0.014257120312211225,15.087855297157622,64.1309112278656,"['CEBPB', 'CEBPD']",0.15207594999691973,0,0,2
32,Farnesoid X receptor pathway WP2879,0.014257120312211225,15.087855297157622,64.1309112278656,"['IRS2', 'FKBP5']",0.15207594999691973,0,0,2
33,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.014257120312211225,15.087855297157622,64.1309112278656,"['SOCS3', 'CHI3L1']",0.15207594999691973,0,0,2
34,Complement system WP2806,0.015002725241209536,4.657742257742258,19.560297656749974,"['C1R', 'PROS1', 'SERPING1', 'ICAM1']",0.15532233190899286,0,0,4
35,MAPK Signaling Pathway WP382,0.018712827640822702,2.080901856763926,8.278963800642574,"['PTPRR', 'IL1R1', 'GADD45A', 'EGF', 'HSPB1', 'PTPN7', 'MAP3K6', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A', 'TNFRSF1A']",0.18489492864459858,0,0,12
36,Prostaglandin Synthesis and Regulation WP98,0.0189097086113794,6.045077720207254,23.987350825228575,"['HSD11B1', 'EDNRA', 'S100A6']",0.18489492864459858,0,0,3
37,IL-18 signaling pathway WP4754,0.020930867690351733,2.1224968186993505,8.206698232726138,"['ACTA2', 'SOCS3', 'CEBPB', 'TMSB4X', 'RGS16', 'IL18', 'HSPB1', 'TNFRSF11B', 'PTPN7', 'ICAM1', 'TNFRSF1A']",0.1991260926217246,0,0,11
38,Wnt signaling pathway and pluripotency WP399,0.025008752440830406,2.843831592689295,10.489556488762998,"['FZD4', 'WNT7B', 'WNT7A', 'PRKCQ', 'LDLR', 'CD44']",0.2301643229176088,0,0,6
39,Development and heterogeneity of the ILC family WP3893,0.025501160777803247,10.056847545219638,36.89888849470206,"['NFIL3', 'IL18']",0.2301643229176088,0,0,2
40,Wnt signaling in kidney disease WP4150,0.028711290964840343,5.036269430051814,17.88109743631801,"['FZD4', 'WNT7B', 'WNT7A']",0.24649693706399517,0,0,3
41,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.028711290964840343,5.036269430051814,17.88109743631801,"['HSPB1', 'NDRG1', 'RAB11A']",0.24649693706399517,0,0,3
42,Peptide GPCRs WP24,0.032097688113336395,8.619416758951642,29.64192662259469,"['OXTR', 'EDNRA']",0.2600679795781966,0,0,2
43,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.03247087956902528,4.770793564221434,16.351473225006266,"['ACAP1', 'IL18', 'NOD1']",0.2600679795781966,0,0,3
44,Nuclear Receptors Meta-Pathway WP2882,0.032508497447274576,1.970619358854653,6.751841995499796,"['GADD45B', 'HGF', 'IRS2', 'ANGPTL4', 'GCLM', 'JUNB', 'SLC5A3', 'SLC39A14', 'CYP3A5', 'HSPA1A', 'FKBP5']",0.2600679795781966,0,0,11
45,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.03355140563932512,2.4142670157068062,8.195655550245027,"['CLDN11', 'COL4A1', 'SHC1', 'FZD4', 'WNT7B', 'PIK3CD', 'WNT7A']",0.2624465507787209,0,0,7
46,Eicosanoid Synthesis WP167,0.03928068452986702,7.541343669250646,24.41149814754123,"['PNPLA3', 'PLA2G5']",0.28103254493131014,0,0,2
47,Hypertrophy Model WP516,0.03928068452986702,7.541343669250646,24.41149814754123,"['IL1R1', 'IL18']",0.28103254493131014,0,0,2
48,ID signaling pathway WP53,0.03928068452986702,7.541343669250646,24.41149814754123,"['ID3', 'ELK3']",0.28103254493131014,0,0,2
49,Overview of nanoparticle effects WP3287,0.03928068452986702,7.541343669250646,24.41149814754123,"['COL4A1', 'PIK3CD']",0.28103254493131014,0,0,2
50,Signal transduction through IL1R WP4496,0.0407177834985705,4.315692079940785,13.814920231689204,"['IL1R1', 'IL1RAP', 'MAP3K14']",0.28103254493131014,0,0,3
51,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.0407177834985705,4.315692079940785,13.814920231689204,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.28103254493131014,0,0,3
52,TP53 network WP1742,0.047005705563719094,6.702842377260982,20.49384867027512,"['CDKN1A', 'GADD45A']",0.30640756219313187,0,0,2
53,Imatinib and Chronic Myeloid Leukemia WP3640,0.047005705563719094,6.702842377260982,20.49384867027512,"['GADD45A', 'PIM1']",0.30640756219313187,0,0,2
54,Leptin Insulin Overlap WP3935,0.047005705563719094,6.702842377260982,20.49384867027512,"['SOCS3', 'IRS2']",0.30640756219313187,0,0,2
55,Non-small cell lung cancer WP4255,0.049066394375960574,2.6555646929824563,8.005414630789922,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD']",0.31374509000471307,0,0,5
56,Oxidative Damage WP3941,0.0499139915916589,3.9397386798828564,11.80918516125085,"['CDKN1A', 'C1R', 'GADD45A']",0.31374509000471307,0,0,3
57,Selenium Micronutrient Network WP15,0.052447311608416695,3.023896103896104,8.914283033899732,"['SERPINA3', 'SOD2', 'LDLR', 'ICAM1']",0.3238851523888189,0,0,4
58,The influence of laminopathies on Wnt signaling WP4844,0.05485811497991448,3.775259067357513,10.9595965325599,"['CEBPB', 'CEBPD', 'HES5']",0.3272890927615237,0,0,3
59,IL17 signaling pathway WP2112,0.05485811497991448,3.775259067357513,10.9595965325599,"['CEBPB', 'CEBPD', 'MAP3K14']",0.3272890927615237,0,0,3
60,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.060015935534106335,2.8794063079777366,8.100187918351482,"['IL1R1', 'IRF7', 'IL1RAP', 'MAP3K14']",0.34638322110954706,0,0,4
61,Bladder cancer WP2828,0.06002663774909764,3.623937823834197,10.194016975043835,"['CDKN1A', 'EGF', 'FGFR3']",0.34638322110954706,0,0,3
62,EV release from cardiac cells and their functional effects WP3297,0.06341580912521973,30.105670103092784,83.03270539240025,['RGS16'],0.35153337685135094,0,0,1
63,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.06391515942751835,5.483204134366925,15.079900931505433,"['EGF', 'HSPB1']",0.35153337685135094,0,0,2
64,Phytochemical activity on NRF2 transcriptional activation WP3,0.06391515942751835,5.483204134366925,15.079900931505433,"['CEBPB', 'GCLM']",0.35153337685135094,0,0,2
65,DNA damage response WP707,0.06813180159818526,2.748051948051948,7.382122701526156,"['CDKN1A', 'GADD45B', 'GADD45A', 'TNFRSF10B']",0.3644747827299855,0,0,4
66,Aryl Hydrocarbon Receptor Netpath WP2586,0.07101563214527631,3.354922279792746,8.873283822211176,"['CDKN1A', 'KLF6', 'PSRC1']",0.3644747827299855,0,0,3
67,Type 2 papillary renal cell carcinoma WP4241,0.07101563214527631,3.354922279792746,8.873283822211176,"['CDKN1A', 'EGLN3', 'COL21A1']",0.3644747827299855,0,0,3
68,NAD+ metabolism WP3644,0.07302152972826667,5.025839793281654,13.152627531316758,"['NT5E', 'NAMPT']",0.3644747827299855,0,0,2
69,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.07302152972826667,5.025839793281654,13.152627531316758,"['ICAM1', 'TNFRSF1A']",0.3644747827299855,0,0,2
70,Small cell lung cancer WP4658,0.07485218719927329,2.3271233974358974,6.03246223346552,"['CDKN1A', 'GADD45B', 'COL4A1', 'GADD45A', 'PIK3CD']",0.3644747827299855,0,0,5
71,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.07485218719927329,2.3271233974358974,6.03246223346552,"['SHC1', 'EGF', 'HGF', 'PIK3CD', 'FGFR3']",0.3644747827299855,0,0,5
72,Ebola Virus Pathway on Host WP4217,0.076353753066598,2.112332260610845,5.433717231164504,"['SOCS3', 'CAV3', 'ACTN1', 'NEDD4', 'IRF7', 'PIK3CD']",0.3644747827299855,0,0,6
73,miRNA regulation of DNA damage response WP1530,0.07678400529557093,2.628119706380576,6.7457497120556384,"['CDKN1A', 'GADD45B', 'GADD45A', 'TNFRSF10B']",0.3644747827299855,0,0,4
74,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.0768246338851528,3.234826054774241,8.301307461280837,"['CDKN1A', 'JUNB', 'TNFRSF1A']",0.3644747827299855,0,0,3
75,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.08130706598667266,2.5719812102790827,6.454444340491343,"['CDKN1A', 'SHC1', 'FZD4', 'TMSB4X']",0.3644747827299855,0,0,4
76,Statin inhibition of cholesterol production WP430,0.08251361570006625,4.638839196978732,11.572938734536685,"['APOC1', 'LDLR']",0.3644747827299855,0,0,2
77,Cholesterol Biosynthesis Pathway WP197,0.08251361570006625,4.638839196978732,11.572938734536685,"['MSMO1', 'DHCR7']",0.3644747827299855,0,0,2
78,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.08251361570006625,4.638839196978732,11.572938734536685,"['ACTN1', 'PRKCQ']",0.3644747827299855,0,0,2
79,Purinergic signaling WP4900,0.08251361570006625,4.638839196978732,11.572938734536685,"['P2RY12', 'P2RY14']",0.3644747827299855,0,0,2
80,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.08283517789317851,3.1230123280328748,7.779119071873612,"['IFITM3', 'IFITM2', 'JUNB']",0.3644747827299855,0,0,3
81,Senescence and Autophagy in Cancer WP615,0.08609983072903721,2.2238817401960786,5.453509179425805,"['CDKN1A', 'CEBPB', 'IFI16', 'IRF7', 'CD44']",0.369599273373428,0,0,5
82,Pancreatic adenocarcinoma pathway WP4263,0.08609983072903721,2.2238817401960786,5.453509179425805,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD']",0.369599273373428,0,0,5
83,Ferroptosis WP4313,0.08904086514867862,3.0186528497409326,7.301094465833917,"['GCLM', 'CP', 'SLC39A14']",0.3744124574709832,0,0,3
84,Apoptosis Modulation by HSP70 WP384,0.09235724735103719,4.307124400147656,10.25996269335822,"['TNFRSF1A', 'HSPA1A']",0.3744124574709832,0,0,2
85,Tamoxifen metabolism WP691,0.0936031143677458,15.051546391752577,35.65247184972146,['CYP3A5'],0.3744124574709832,0,0,1
86,Composition of Lipid Particles WP3601,0.0936031143677458,15.051546391752577,35.65247184972146,['LDLR'],0.3744124574709832,0,0,1
87,Hypothetical Craniofacial Development Pathway WP3655,0.0936031143677458,15.051546391752577,35.65247184972146,['ARHGAP29'],0.3744124574709832,0,0,1
88,Macrophage markers WP4146,0.0936031143677458,15.051546391752577,35.65247184972146,['F3'],0.3744124574709832,0,0,1
89,Sleep regulation WP3591,0.10252004648006582,4.0196382428940565,9.155517661877838,"['OXTR', 'IL18']",0.39578278196006456,0,0,2
90,Monoamine Transport WP727,0.10252004648006582,4.0196382428940565,9.155517661877838,"['IL1R1', 'TNFRSF11B']",0.39578278196006456,0,0,2
91,IL-6 signaling pathway WP364,0.10876197836228198,2.743523316062176,6.086762911665295,"['SOCS3', 'SHC1', 'JUNB']",0.39578278196006456,0,0,3
92,Notch Signaling WP268,0.10876197836228198,2.743523316062176,6.086762911665295,"['LFNG', 'DTX3L', 'HES5']",0.39578278196006456,0,0,3
93,Melanoma WP4685,0.11107167039975648,2.2796373437882873,5.009684537503763,"['CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD']",0.39578278196006456,0,0,4
94,Striated Muscle Contraction Pathway WP383,0.11297134712702193,3.7680878552971575,8.216771724413427,"['ACTA2', 'ACTN2']",0.39578278196006456,0,0,2
95,White fat cell differentiation WP4149,0.11297134712702193,3.7680878552971575,8.216771724413427,"['CEBPB', 'CEBPD']",0.39578278196006456,0,0,2
96,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.11297134712702193,3.7680878552971575,8.216771724413427,"['BCL6', 'H2AFJ']",0.39578278196006456,0,0,2
97,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.11297134712702193,3.7680878552971575,8.216771724413427,"['UGCG', 'GALNT16']",0.39578278196006456,0,0,2
98,Metapathway biotransformation Phase I and II WP702,0.11553743794452485,2.0151041666666667,4.34891854534254,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'CHST6', 'CYP3A5']",0.39578278196006456,0,0,5
99,TGF-beta Receptor Signaling WP560,0.11568070690148,2.662602864980189,5.743025125149705,"['SMAD1', 'EGF', 'SMAD9']",0.39578278196006456,0,0,3
100,Neural Crest Differentiation WP2064,0.11644767001148247,2.2372294372294372,4.810744194653204,"['SMAD1', 'FGFR3', 'HES5', 'GFAP']",0.39578278196006456,0,0,4
101,Glycogen Synthesis and Degradation WP500,0.12276018689101993,2.586306439674315,5.424836018481728,"['PYGM', 'PYGL', 'GYG2']",0.39578278196006456,0,0,3
102,IL-3 signaling pathway WP286,0.12276018689101993,2.586306439674315,5.424836018481728,"['SHC1', 'PIK3CD', 'ENPP3']",0.39578278196006456,0,0,3
103,Blood Clotting Cascade WP272,0.122819872326243,10.033505154639176,21.040626026534824,['F3'],0.39578278196006456,0,0,1
104,Cells and molecules involved in local acute inflammatory response  WP4493,0.122819872326243,10.033505154639176,21.040626026534824,['ICAM1'],0.39578278196006456,0,0,1
105,Irinotecan pathway WP229,0.122819872326243,10.033505154639176,21.040626026534824,['CYP3A5'],0.39578278196006456,0,0,1
106,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.122819872326243,10.033505154639176,21.040626026534824,['CDKN1A'],0.39578278196006456,0,0,1
107,Osteoblast Signaling WP322,0.122819872326243,10.033505154639176,21.040626026534824,['TNFRSF11B'],0.39578278196006456,0,0,1
108,7-oxo-C and 7beta-HC pathways WP5064,0.12368211936252016,3.5461316309469524,7.411558934228578,"['HSD11B1', 'DHCR7']",0.39578278196006456,0,0,2
109,TYROBP causal network in microglia WP3945,0.12368211936252016,3.5461316309469524,7.411558934228578,"['IL18', 'IL13RA1']",0.39578278196006456,0,0,2
110,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.12368211936252016,3.5461316309469524,7.411558934228578,"['CEBPB', 'ATP2C2']",0.39578278196006456,0,0,2
111,NRF2 pathway WP2884,0.1294470524406583,1.937099358974359,3.9603673729871955,"['HGF', 'GCLM', 'SLC5A3', 'SLC39A14', 'HSPA1A']",0.4104987608928984,0,0,5
112,Myometrial relaxation and contraction pathways WP289,0.1313910460800359,1.7962929452214151,3.6457154175998814,"['RGS4', 'ACTA2', 'OXTR', 'GRK5', 'RGS16', 'PRKCQ']",0.41294328768011285,0,0,6
113,Unfolded protein response WP4925,0.1346248960937726,3.3488372093023258,6.715299065276375,"['TNFRSF10B', 'TXNIP']",0.4156838896930522,0,0,2
114,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.1346248960937726,3.3488372093023258,6.715299065276375,"['CDKN1A', 'FGFR3']",0.4156838896930522,0,0,2
115,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.1442118341050586,1.744024904599317,3.377255377960586,"['SHC1', 'TRIP10', 'PIK3CD', 'IRS2', 'MAP3K6', 'MAP3K14']",0.42548972931434564,0,0,6
116,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.14489134514226865,2.381510771748023,4.600533829203429,"['SMAD1', 'EGF', 'SMAD9']",0.42548972931434564,0,0,3
117,EPO Receptor Signaling WP581,0.14577370292453998,3.172310621515028,6.108918055343881,"['SHC1', 'IRS2']",0.42548972931434564,0,0,2
118,miRNAs involvement in the immune response in sepsis WP4329,0.14577370292453998,3.172310621515028,6.108918055343881,"['IRF7', 'ICAM1']",0.42548972931434564,0,0,2
119,NRF2-ARE regulation WP4357,0.14577370292453998,3.172310621515028,6.108918055343881,"['CEBPB', 'GCLM']",0.42548972931434564,0,0,2
120,Oxidative Stress WP408,0.14577370292453998,3.172310621515028,6.108918055343881,"['SOD2', 'JUNB']",0.42548972931434564,0,0,2
121,Serotonin Transporter Activity WP1455,0.15109720501219662,7.524484536082475,14.220010963609397,['IL1R1'],0.42548972931434564,0,0,1
122,Bile acids synthesis and enterohepatic circulation  WP4389,0.15109720501219662,7.524484536082475,14.220010963609397,['LDLR'],0.42548972931434564,0,0,1
123,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.15109720501219662,7.524484536082475,14.220010963609397,['HSD11B1'],0.42548972931434564,0,0,1
124,Vitamin D Metabolism WP1531,0.15109720501219662,7.524484536082475,14.220010963609397,['DHCR7'],0.42548972931434564,0,0,1
125,miR-517 relationship with ARCN1 and USP1 WP3596,0.15109720501219662,7.524484536082475,14.220010963609397,['CDKN1A'],0.42548972931434564,0,0,1
126,Exercise-induced Circadian Regulation WP410,0.15254192838896524,2.320247110402551,4.362797256275906,"['CEBPB', 'RBPMS', 'ETV6']",0.42614887930885526,0,0,3
127,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.15710399089851376,3.0134366925064597,5.577411257920406,"['P4HA2', 'TNFRSF11B']",0.42743718021866056,0,0,2
128,Vitamin A and carotenoid metabolism WP716,0.15710399089851376,3.0134366925064597,5.577411257920406,"['RBP1', 'BCO1']",0.42743718021866056,0,0,2
129,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.15710399089851376,3.0134366925064597,5.577411257920406,"['RAB13', 'NDRG1']",0.42743718021866056,0,0,2
130,Focal Adhesion WP306,0.15786032223984622,1.6157827424963032,2.9828071251610133,"['CAV3', 'COL4A1', 'SHC1', 'EGF', 'ACTN1', 'HGF', 'PIK3CD']",0.42743718021866056,0,0,7
131,EGF/EGFR signaling pathway WP437,0.16197068348679206,1.6034031413612566,2.9187387561058116,"['PTPRR', 'PLSCR1', 'SHC1', 'EGF', 'LIMK2', 'NEDD4', 'PLCE1']",0.43192182263144546,0,0,7
132,Insulin Signaling WP481,0.16197068348679206,1.6034031413612566,2.9187387561058116,"['SOCS3', 'SHC1', 'PIK3CD', 'IRS2', 'PRKCQ', 'MAP3K6', 'MAP3K14']",0.43192182263144546,0,0,7
133,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.16779437273424833,1.4882226056945642,2.6565011940745755,"['EFNA1', 'CDKN1A', 'COL4A1', 'EGF', 'HGF', 'PIK3CD', 'IRS2', 'OSMR', 'FGFR3']",0.43342277992024186,0,0,9
134,Oxidation by Cytochrome P450 WP43,0.16859257193514018,2.8696936138796603,5.108830287097378,"['CYP39A1', 'CYP3A5']",0.43342277992024186,0,0,2
135,Corticotropin-releasing hormone signaling pathway WP2355,0.17584528677015576,1.886038961038961,3.278219983697288,"['IL18', 'PRKCQ', 'JUNB', 'FOSL2']",0.43342277992024186,0,0,4
136,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.17621358983515187,2.153960029607698,3.7394004912494316,"['WIF1', 'WNT7B', 'WNT7A']",0.43342277992024186,0,0,3
137,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.17846524118542834,6.0190721649484535,10.373036777204439,['LFNG'],0.43342277992024186,0,0,1
138,Caloric restriction and aging WP4191,0.17846524118542834,6.0190721649484535,10.373036777204439,['NAMPT'],0.43342277992024186,0,0,1
139,Complement Activation WP545,0.17846524118542834,6.0190721649484535,10.373036777204439,['C1R'],0.43342277992024186,0,0,1
140,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.17846524118542834,6.0190721649484535,10.373036777204439,['CEBPB'],0.43342277992024186,0,0,1
141,Genes targeted by miRNAs in adipocytes WP1992,0.17846524118542834,6.0190721649484535,10.373036777204439,['TMSB4X'],0.43342277992024186,0,0,1
142,LDLRAD4 and what we know about it WP4904,0.17846524118542834,6.0190721649484535,10.373036777204439,['NEDD4'],0.43342277992024186,0,0,1
143,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.17846524118542834,6.0190721649484535,10.373036777204439,['LDLR'],0.43342277992024186,0,0,1
144,Platelet-mediated interactions with vascular and circulating cells WP4462,0.17846524118542834,6.0190721649484535,10.373036777204439,['ICAM1'],0.43342277992024186,0,0,1
145,Neovascularisation processes WP4331,0.18021755709344844,2.739018087855297,4.693555394953388,"['SMAD1', 'SMAD9']",0.43342277992024186,0,0,2
146,Oxysterols derived from cholesterol WP4545,0.18021755709344844,2.739018087855297,4.693555394953388,"['CYP39A1', 'DHCR7']",0.43342277992024186,0,0,2
147,Integrated breast cancer pathway WP1984,0.18100326320532828,1.6183327116747481,2.7661193587121846,"['SMAD1', 'ITPKC', 'RASGEF1A', 'GADD45A', 'FAU', 'FOSL2']",0.43342277992024186,0,0,6
148,Interferon type I signaling pathways WP585,0.18432040505254807,2.1036871912278587,3.5575027124951757,"['SOCS3', 'PIK3CD', 'IRS2']",0.43838366607092516,0,0,3
149,Resistin as a regulator of inflammation WP4481,0.1919582971398076,2.619705651050444,4.323764272100437,"['PIK3CD', 'PLCE1']",0.4517888475006563,0,0,2
150,Cardiac Hypertrophic Response WP2795,0.1925236566053933,2.055699481865285,3.3868393976938687,"['EGF', 'MAP3K14', 'TNFRSF1A']",0.4517888475006563,0,0,3
151,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.20081644861534154,2.0098445595854924,3.226532059557496,"['ACTN2', 'ACTN1', 'DSC2']",0.45373275208197245,0,0,3
152,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.20081644861534154,2.0098445595854924,3.226532059557496,"['PLCE1', 'PRKCQ', 'TNFRSF1A']",0.45373275208197245,0,0,3
153,Pyrimidine metabolism WP4022,0.2020280785828287,1.7744843391902216,2.838019022943085,"['NT5C', 'POLE4', 'ENPP3', 'POLR2I']",0.45373275208197245,0,0,4
154,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.20379532584358395,2.5103359173126614,3.9930384478276415,"['PIK3CD', 'PRKCQ']",0.45373275208197245,0,0,2
155,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.20495314653702734,5.015463917525773,7.94937930257208,['DHCR7'],0.45373275208197245,0,0,1
156,Dual hijack model of Vif in HIV infection WP3300,0.20495314653702734,5.015463917525773,7.94937930257208,['RUNX1'],0.45373275208197245,0,0,1
157,Gene regulatory network modelling somitogenesis  WP2854,0.20495314653702734,5.015463917525773,7.94937930257208,['LFNG'],0.45373275208197245,0,0,1
158,Nanoparticle triggered regulated necrosis WP2513,0.20495314653702734,5.015463917525773,7.94937930257208,['TNFRSF1A'],0.45373275208197245,0,0,1
159,Osteoclast Signaling WP12,0.20495314653702734,5.015463917525773,7.94937930257208,['TNFRSF11B'],0.45373275208197245,0,0,1
160,IL-1 signaling pathway WP195,0.20919198018953994,1.965983329578734,3.0757865873316,"['IL1R1', 'IL1RAP', 'MAP3K14']",0.45736383246408735,0,0,3
161,p53 transcriptional gene network WP4963,0.20919198018953994,1.965983329578734,3.0757865873316,"['CDKN1A', 'GADD45A', 'ICAM1']",0.45736383246408735,0,0,3
162,Notch Signaling Pathway Netpath WP61,0.2176435543130881,1.923988534891412,2.9338836259735293,"['HES6', 'CDKN1A', 'HES5']",0.4719033850605085,0,0,3
163,TNF-alpha signaling pathway WP231,0.2223755081019528,1.6990671300530455,2.5543568764462763,"['OTUD7B', 'PYGL', 'MAP3K14', 'TNFRSF1A']",0.4719033850605085,0,0,4
164,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.2261645858730495,1.8837435233160622,2.8001702212681168,"['CDKN1A', 'PLCE1', 'MYH9']",0.4719033850605085,0,0,3
165,Alpha 6 Beta 4 signaling pathway WP244,0.22768597432985965,2.3168356191612007,3.4284253270050833,"['SHC1', 'IRS2']",0.4719033850605085,0,0,2
166,Cancer immunotherapy by CTLA4 blockade WP4582,0.23058915406365754,4.29860088365243,6.306553466582789,['PIK3CD'],0.4719033850605085,0,0,1
167,Trans-sulfuration pathway WP2333,0.23058915406365754,4.29860088365243,6.306553466582789,['GCLM'],0.4719033850605085,0,0,1
168,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.23058915406365754,4.29860088365243,6.306553466582789,['PRKCQ'],0.4719033850605085,0,0,1
169,Galanin receptor pathway WP4970,0.23058915406365754,4.29860088365243,6.306553466582789,['CDKN1A'],0.4719033850605085,0,0,1
170,Inflammatory Response Pathway WP453,0.23058915406365754,4.29860088365243,6.306553466582789,['TNFRSF1A'],0.4719033850605085,0,0,1
171,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.23058915406365754,4.29860088365243,6.306553466582789,['EGF'],0.4719033850605085,0,0,1
172,RAS and bradykinin pathways in COVID-19 WP4969,0.23058915406365754,4.29860088365243,6.306553466582789,['SERPING1'],0.4719033850605085,0,0,1
173,ATM Signaling Pathway WP2516,0.23970609736950668,2.23083548664944,3.186395352229129,"['CDKN1A', 'GADD45A']",0.48772570100616386,0,0,2
174,Apoptosis WP254,0.24338928278445504,1.8080829015544042,2.5549895278978894,"['IRF7', 'TNFRSF10B', 'TNFRSF1A']",0.489560157372161,0,0,3
175,MET in type 1 papillary renal cell carcinoma WP4205,0.24338928278445504,1.8080829015544042,2.5549895278978894,"['CDKN1A', 'HGF', 'PIK3CD']",0.489560157372161,0,0,3
176,ErbB signaling pathway WP673,0.25027888330827147,1.607896103896104,2.2272246402596956,"['CDKN1A', 'SHC1', 'EGF', 'PIK3CD']",0.5005577666165429,0,0,4
177,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.2520803980960288,1.7724779030783298,2.4424873163410465,"['WIF1', 'WNT7B', 'WNT7A']",0.5013124301118764,0,0,3
178,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.2554005936115248,3.760953608247423,5.13340836278812,['PRKCQ'],0.5015131838588289,0,0,1
179,"NAD metabolism, sirtuins and aging WP3630",0.2554005936115248,3.760953608247423,5.13340836278812,['NAMPT'],0.5015131838588289,0,0,1
180,TGF-beta Signaling Pathway WP366,0.25645560538235573,1.4930125825082508,2.0316910859927857,"['CDKN1A', 'KLF6', 'SHC1', 'LIMK2', 'JUNB']",0.5015131838588289,0,0,5
181,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2695897988863509,1.7052986606706424,2.2353971248012288,"['RNF19A', 'HSPA1B', 'HSPA1A']",0.5093205012358145,0,0,3
182,Hepatitis C and Hepatocellular Carcinoma WP3646,0.2758852394598397,2.007235142118863,2.5848577987120844,"['CDKN1A', 'CD44']",0.5093205012358145,0,0,2
183,p38 MAPK Signaling Pathway WP400,0.2758852394598397,2.007235142118863,2.5848577987120844,"['SHC1', 'HSPB1']",0.5093205012358145,0,0,2
184,MECP2 and Associated Rett Syndrome WP3584,0.27839636141817237,1.6735751295336787,2.1400162835905197,"['CEBPD', 'BCL6', 'FKBP5']",0.5093205012358145,0,0,3
185,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.2794139204799695,3.3427835051546393,4.262252914424618,['SMAD1'],0.5093205012358145,0,0,1
186,FOXA2 pathway WP5066,0.2794139204799695,3.3427835051546393,4.262252914424618,['IRS2'],0.5093205012358145,0,0,1
187,Ganglio Sphingolipid Metabolism WP1423,0.2794139204799695,3.3427835051546393,4.262252914424618,['ST8SIA1'],0.5093205012358145,0,0,1
188,Glutathione metabolism WP100,0.2794139204799695,3.3427835051546393,4.262252914424618,['GCLM'],0.5093205012358145,0,0,1
189,Kynurenine Pathway and links to Cellular Senescence WP5044,0.2794139204799695,3.3427835051546393,4.262252914424618,['CDKN1A'],0.5093205012358145,0,0,1
190,miR-509-3p alteration of YAP1/ECM axis WP3967,0.2794139204799695,3.3427835051546393,4.262252914424618,['EDNRA'],0.5093205012358145,0,0,1
191,miRNAs involved in DNA damage response WP1545,0.2794139204799695,3.3427835051546393,4.262252914424618,['CDKN1A'],0.5093205012358145,0,0,1
192,NOTCH1 regulation of endothelial cell calcification WP3413,0.2794139204799695,3.3427835051546393,4.262252914424618,['FGFR3'],0.5093205012358145,0,0,1
193,Osteopontin Signaling WP1434,0.2794139204799695,3.3427835051546393,4.262252914424618,['MAP3K14'],0.5093205012358145,0,0,1
194,Calcium Regulation in the Cardiac Cell WP536,0.2811718593681606,1.435639880952381,1.8215243723434524,"['RGS4', 'PLN', 'GRK5', 'RGS16', 'PRKCQ']",0.5093205012358145,0,0,5
195,PI3K-Akt signaling pathway WP4172,0.28397288692880074,1.3049017521458466,1.6427101687741321,"['EFNA1', 'CDKN1A', 'COL4A1', 'EGF', 'HGF', 'PIK3CD', 'OSMR', 'FGFR3']",0.5093205012358145,0,0,8
196,Cell cycle WP179,0.2861022065729576,1.5067532467532467,1.885560304173676,"['CDKN1A', 'GADD45B', 'GADD45A', 'CDC7']",0.5093205012358145,0,0,4
197,Regulation of Actin Cytoskeleton WP51,0.28742483150904147,1.4219732704402517,1.7729076117071596,"['EGF', 'ACTN1', 'TMSB4X', 'PIK3CD', 'FGFR3']",0.5093205012358145,0,0,5
198,IL-2 signaling pathway WP49,0.28793971518729283,1.9423189130615988,2.4181950938345893,"['SOCS3', 'SHC1']",0.5093205012358145,0,0,2
199,Phosphoinositides metabolism WP4971,0.28793971518729283,1.9423189130615988,2.4181950938345893,"['PIK3CD', 'PLCE1']",0.5093205012358145,0,0,2
200,T-cell receptor (TCR) signaling pathway WP69,0.2960849993227789,1.6135270170244262,1.9638377797968514,"['SHC1', 'PRKCQ', 'MAP3K14']",0.5097343048579619,0,0,3
201,Nephrotic syndrome WP4758,0.2999712534372262,1.8814599483204135,2.265406903866138,"['PLCE1', 'MYH9']",0.5097343048579619,0,0,2
202,Gastrin signaling pathway WP4659,0.3006425259746869,1.4697497624326892,1.7663942679488733,"['CDKN1A', 'SHC1', 'PRKCQ', 'CD44']",0.5097343048579619,0,0,4
203,Biomarkers for pyrimidine metabolism disorders WP4584,0.3026547435094149,3.0082474226804123,3.59534476154687,['NT5C'],0.5097343048579619,0,0,1
204,BMP Signaling Pathway in Eyelid Development WP3927,0.3026547435094149,3.0082474226804123,3.59534476154687,['SMAD1'],0.5097343048579619,0,0,1
205,Tryptophan catabolism leading to NAD+ production WP4210,0.3026547435094149,3.0082474226804123,3.59534476154687,['NAMPT'],0.5097343048579619,0,0,1
206,Fatty acid transporters WP5061,0.3026547435094149,3.0082474226804123,3.59534476154687,['FABP5'],0.5097343048579619,0,0,1
207,GPR40 Pathway WP3958,0.3026547435094149,3.0082474226804123,3.59534476154687,['PLCE1'],0.5097343048579619,0,0,1
208,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3026547435094149,3.0082474226804123,3.59534476154687,['MAP3K14'],0.5097343048579619,0,0,1
209,RalA downstream regulated genes WP2290,0.3026547435094149,3.0082474226804123,3.59534476154687,['YBX3'],0.5097343048579619,0,0,1
210,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.31196883754622196,1.8242894056847545,2.1250271186803014,"['CXCL17', 'IRF7']",0.5229191943631911,0,0,2
211,Retinoblastoma gene in cancer WP2446,0.3138384558787751,1.557620153653743,1.8050900106567593,"['CDKN1A', 'RBP1', 'CDC7']",0.5235598884802315,0,0,3
212,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3227266144029033,1.5310880829015545,1.7315836221040146,"['CDKN1A', 'GADD45B', 'GADD45A']",0.5298705733450463,0,0,3
213,Prolactin Signaling Pathway WP2037,0.3227266144029033,1.5310880829015545,1.7315836221040146,"['SOCS3', 'SHC1', 'IRS2']",0.5298705733450463,0,0,3
214,Cysteine and methionine catabolism WP4504,0.3251478518253693,2.734536082474227,3.072183667431717,['SQOR'],0.5298705733450463,0,0,1
215,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3251478518253693,2.734536082474227,3.072183667431717,['SYTL4'],0.5298705733450463,0,0,1
216,Pyrimidine metabolism and related diseases WP4225,0.3251478518253693,2.734536082474227,3.072183667431717,['NT5C'],0.5298705733450463,0,0,1
217,Interleukin-11 Signaling Pathway WP2332,0.33582169234840753,1.7197489848652638,1.8765469909257249,"['SOCS3', 'ICAM1']",0.5438923163546834,0,0,2
218,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.34691724113595224,2.506443298969072,2.6534938851609784,['F3'],0.5438923163546834,0,0,1
219,miRNA targets in ECM and membrane receptors WP2911,0.34691724113595224,2.506443298969072,2.6534938851609784,['COL4A1'],0.5438923163546834,0,0,1
220,Omega-3/Omega-6 FA synthesis WP4723,0.34691724113595224,2.506443298969072,2.6534938851609784,['PLA2G5'],0.5438923163546834,0,0,1
221,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.34691724113595224,2.506443298969072,2.6534938851609784,['BCL2L14'],0.5438923163546834,0,0,1
222,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3476584408517152,1.6718346253229974,1.7663514163450607,"['PRKCQ', 'MAP3K14']",0.5438923163546834,0,0,2
223,Endochondral Ossification with Skeletal Dysplasias WP4808,0.3476584408517152,1.6718346253229974,1.7663514163450607,"['ADAMTS1', 'FGFR3']",0.5438923163546834,0,0,2
224,Endochondral Ossification WP474,0.3476584408517152,1.6718346253229974,1.7663514163450607,"['ADAMTS1', 'FGFR3']",0.5438923163546834,0,0,2
225,One-carbon metabolism and related pathways WP3940,0.3476584408517152,1.6718346253229974,1.7663514163450607,"['SOD2', 'GCLM']",0.5438923163546834,0,0,2
226,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.3582433738781964,1.433382679496669,1.471428537767666,"['EGF', 'PIK3CD', 'MAP3K14']",0.5579719805536509,0,0,3
227,Amino Acid metabolism WP3925,0.36709112631869123,1.4108646373056994,1.4138911693180274,"['WARS', 'P4HA2', 'GCLM']",0.5679612410920838,0,0,3
228,ERK Pathway in Huntington's Disease WP3853,0.3679861391162958,2.3134417129262492,2.3127708309482093,['EGF'],0.5679612410920838,0,0,1
229,Cytosolic DNA-sensing pathway WP4655,0.37111103821357744,1.5835713314293485,1.5697213639554342,"['IL18', 'IRF7']",0.5679612410920838,0,0,2
230,Modulators of TCR signaling and T cell activation WP5072,0.37111103821357744,1.5835713314293485,1.5697213639554342,"['PRKCQ', 'MAP3K14']",0.5679612410920838,0,0,2
231,Glioblastoma signaling pathways WP2261,0.37591785537512007,1.389039457951375,1.3590148550220027,"['CDKN1A', 'PIK3CD', 'PRKCQ']",0.5714278627900656,0,0,3
232,Nonalcoholic fatty liver disease WP4396,0.37674875215248105,1.2545572916666667,1.22466966420666,"['SOCS3', 'PIK3CD', 'IRS2', 'COX7A1', 'TNFRSF1A']",0.5714278627900656,0,0,5
233,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3827120454090695,1.5428344265553569,1.481849903356956,"['MSMO1', 'DHCR7']",0.5714278627900656,0,0,2
234,PPAR signaling pathway WP3942,0.3827120454090695,1.5428344265553569,1.481849903356956,"['FABP5', 'ANGPTL4']",0.5714278627900656,0,0,2
235,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.3883770296742938,2.1480117820324005,2.0315437590352907,['LDLR'],0.5714278627900656,0,0,1
236,Constitutive Androstane Receptor Pathway WP2875,0.3883770296742938,2.1480117820324005,2.0315437590352907,['CYP3A5'],0.5714278627900656,0,0,1
237,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.3883770296742938,2.1480117820324005,2.0315437590352907,['PLA2G5'],0.5714278627900656,0,0,1
238,MAPK pathway in congenital thyroid cancer WP4928,0.3883770296742938,2.1480117820324005,2.0315437590352907,['SHC1'],0.5714278627900656,0,0,1
239,Pregnane X receptor pathway WP2876,0.3883770296742938,2.1480117820324005,2.0315437590352907,['CYP3A5'],0.5714278627900656,0,0,1
240,Circadian rhythm related genes WP3594,0.38960990644777205,1.2337773224043715,1.1629699539339917,"['NFIL3', 'NAMPT', 'ID3', 'CARTPT', 'RPS27A']",0.5714278627900656,0,0,5
241,G1 to S cell cycle control WP45,0.39422054832288,1.5041343669250646,1.400115592251689,"['CDKN1A', 'GADD45A']",0.5757910083388122,0,0,2
242,Glucocorticoid Receptor Pathway WP2880,0.40563046136410713,1.467322115081616,1.3239834198429632,"['GADD45B', 'ANGPTL4']",0.5839646760124751,0,0,2
243,Gastric Cancer Network 1 WP2361,0.40811167698599116,2.004639175257732,1.7965865436391568,['GATD3A'],0.5839646760124751,0,0,1
244,Microglia Pathogen Phagocytosis Pathway WP3937,0.40811167698599116,2.004639175257732,1.7965865436391568,['PIK3CD'],0.5839646760124751,0,0,1
245,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.40811167698599116,2.004639175257732,1.7965865436391568,['GCLM'],0.5839646760124751,0,0,1
246,"Relationship between inflammation, COX-2 and EGFR WP4483",0.40811167698599116,2.004639175257732,1.7965865436391568,['PIK3CD'],0.5839646760124751,0,0,1
247,Ras signaling WP4223,0.41526716514041306,1.1941964285714286,1.0494994621349718,"['SHC1', 'PLCE1', 'PIK3CD', 'PLA2G5', 'FGFR3']",0.5917803916737122,0,0,5
248,RANKL/RANK signaling pathway WP2018,0.4169361850428427,1.432262827611665,1.2529751779898362,"['TNFRSF11B', 'ICAM1']",0.5917803916737122,0,0,2
249,Angiogenesis WP1539,0.42721114830422646,1.879188144329897,1.5982060989728504,['SMAD1'],0.5943807280754455,0,0,1
250,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.42721114830422646,1.879188144329897,1.5982060989728504,['SHC1'],0.5943807280754455,0,0,1
251,Kallmann's Syndrome WP5074,0.42721114830422646,1.879188144329897,1.5982060989728504,['PRKCQ'],0.5943807280754455,0,0,1
252,NAD+ biosynthetic pathways WP3645,0.42721114830422646,1.879188144329897,1.5982060989728504,['NAMPT'],0.5943807280754455,0,0,1
253,One-carbon metabolism WP241,0.42721114830422646,1.879188144329897,1.5982060989728504,['GLRX'],0.5943807280754455,0,0,1
254,Wnt signaling WP428,0.43680267720592236,1.253238341968912,1.0380243903615596,"['WIF1', 'WNT7B', 'WNT7A']",0.6005261415846164,0,0,3
255,G Protein Signaling Pathways WP35,0.4453312001656618,1.2359642274114557,0.9998171986942077,"['GNA14', 'PRKCQ', 'PDE8B']",0.6005261415846164,0,0,3
256,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.4456958361940923,1.7684960582171012,1.4291544547637995,['IRF7'],0.6005261415846164,0,0,1
257,Ebstein-Barr virus LMP1 signaling WP262,0.4456958361940923,1.7684960582171012,1.4291544547637995,['MAP3K14'],0.6005261415846164,0,0,1
258,Gastric Cancer Network 2 WP2363,0.4456958361940923,1.7684960582171012,1.4291544547637995,['S100A6'],0.6005261415846164,0,0,1
259,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.4456958361940923,1.7684960582171012,1.4291544547637995,['ETV6'],0.6005261415846164,0,0,1
260,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4456958361940923,1.7684960582171012,1.4291544547637995,['TNFRSF10B'],0.6005261415846164,0,0,1
261,Ovarian infertility WP34,0.4456958361940923,1.7684960582171012,1.4291544547637995,['CEBPB'],0.6005261415846164,0,0,1
262,Ectoderm Differentiation WP2858,0.4469825258385497,1.1795263559969442,0.9497968220185042,"['CLDN11', 'FZD4', 'PIM1', 'TNFRSF11B']",0.6005261415846164,0,0,4
263,Kit receptor signaling pathway WP304,0.4610208480950485,1.3072688461970565,1.0122339723206486,"['SHC1', 'JUNB']",0.6066248664452178,0,0,2
264,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.4635854803231921,1.6701030927835052,1.283915948051254,['WIF1'],0.6066248664452178,0,0,1
265,Zinc homeostasis WP3529,0.4635854803231921,1.6701030927835052,1.283915948051254,['SLC39A14'],0.6066248664452178,0,0,1
266,Glycerolipids and Glycerophospholipids WP4722,0.4635854803231921,1.6701030927835052,1.283915948051254,['PNPLA3'],0.6066248664452178,0,0,1
267,Hippo-Yap signaling pathway WP4537,0.4635854803231921,1.6701030927835052,1.283915948051254,['NDRG1'],0.6066248664452178,0,0,1
268,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4635854803231921,1.6701030927835052,1.283915948051254,['NAMPT'],0.6066248664452178,0,0,1
269,PKC-gamma calcium signaling pathway in ataxia WP4760,0.4635854803231921,1.6701030927835052,1.283915948051254,['GNA14'],0.6066248664452178,0,0,1
270,AGE/RAGE pathway WP2324,0.47173696563425227,1.2793446588597503,0.9612147880120508,"['LGALS3', 'SHC1']",0.6127358372813904,0,0,2
271,Regulatory circuits of the STAT3 signaling pathway WP4538,0.47173696563425227,1.2793446588597503,0.9612147880120508,"['SOCS3', 'OSMR']",0.6127358372813904,0,0,2
272,Sphingolipid Metabolism (general overview) WP4725,0.48089918797837977,1.582067281606077,1.1582276903502167,['UGCG'],0.6133207035086582,0,0,1
273,Toll-like Receptor Signaling related to MyD88 WP3858,0.48089918797837977,1.582067281606077,1.1582276903502167,['IRF7'],0.6133207035086582,0,0,1
274,DNA Mismatch Repair WP531,0.48089918797837977,1.582067281606077,1.1582276903502167,['POLE4'],0.6133207035086582,0,0,1
275,Endothelin Pathways WP2197,0.48089918797837977,1.582067281606077,1.1582276903502167,['EDNRA'],0.6133207035086582,0,0,1
276,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.48089918797837977,1.582067281606077,1.1582276903502167,['HGF'],0.6133207035086582,0,0,1
277,Sphingolipid Metabolism (integrated pathway) WP4726,0.49765545446899145,1.5028350515463917,1.0487493829137542,['UGCG'],0.6146481402564385,0,0,1
278,TLR4 Signaling and Tolerance WP3851,0.49765545446899145,1.5028350515463917,1.0487493829137542,['IRF7'],0.6146481402564385,0,0,1
279,Trans-sulfuration and one-carbon metabolism WP2525,0.49765545446899145,1.5028350515463917,1.0487493829137542,['GCLM'],0.6146481402564385,0,0,1
280,Cell migration and invasion through p75NTR WP4561,0.49765545446899145,1.5028350515463917,1.0487493829137542,['EFNA1'],0.6146481402564385,0,0,1
281,Tryptophan metabolism WP465,0.49765545446899145,1.5028350515463917,1.0487493829137542,['WARS'],0.6146481402564385,0,0,1
282,Heart Development WP1591,0.49765545446899145,1.5028350515463917,1.0487493829137542,['SMAD1'],0.6146481402564385,0,0,1
283,Photodynamic therapy-induced unfolded protein response WP3613,0.49765545446899145,1.5028350515463917,1.0487493829137542,['WARS'],0.6146481402564385,0,0,1
284,Pre-implantation embryo WP3527,0.49765545446899145,1.5028350515463917,1.0487493829137542,['ZFP36'],0.6146481402564385,0,0,1
285,SARS-CoV-2 mitochondrial interactions WP5038,0.49765545446899145,1.5028350515463917,1.0487493829137542,['IRF7'],0.6146481402564385,0,0,1
286,AMP-activated protein kinase (AMPK) signaling WP1403,0.5132856778455832,1.1785985712114304,0.7860341553747575,"['CDKN1A', 'PIK3CD']",0.6280660010451167,0,0,2
287,Aryl Hydrocarbon Receptor Pathway WP2873,0.5138721826732773,1.4311487481590575,0.9528312386709015,['JUNB'],0.6280660010451167,0,0,1
288,"GPCRs, Other WP117",0.5138721826732773,1.4311487481590575,0.9528312386709015,['EDNRA'],0.6280660010451167,0,0,1
289,Toll-like Receptor Signaling Pathway WP75,0.5430030471691091,1.1128337639965546,0.6795411961723758,"['IRF7', 'PIK3CD']",0.6544506376294887,0,0,2
290,16p11.2 distal deletion syndrome WP4950,0.5447557864359096,1.3064769161810847,0.7935771813558431,['PLN'],0.6544506376294887,0,0,1
291,Sphingolipid pathway WP1422,0.5447557864359096,1.3064769161810847,0.7935771813558431,['UGCG'],0.6544506376294887,0,0,1
292,Glycerophospholipid Biosynthetic Pathway WP2533,0.5447557864359096,1.3064769161810847,0.7935771813558431,['PIK3CD'],0.6544506376294887,0,0,1
293,Nanoparticle-mediated activation of receptor signaling WP2643,0.5447557864359096,1.3064769161810847,0.7935771813558431,['PIK3CD'],0.6544506376294887,0,0,1
294,BDNF-TrkB Signaling WP3676,0.5594556727835117,1.2519329896907216,0.7271113890414476,['SHC1'],0.6698244789788984,0,0,1
295,Proteasome Degradation WP183,0.5621034960137677,1.072905131044666,0.618067696472136,"['NEDD4', 'PSMB9']",0.6707133240571059,0,0,2
296,Head and Neck Squamous Cell Carcinoma WP4674,0.5714374723762139,1.0539915680674554,0.5898139043026405,"['CDKN1A', 'FGFR3']",0.6795472644473896,0,0,2
297,Proximal tubule transport WP4917,0.573682077362867,1.2017525773195876,0.667789761960104,['SLC3A1'],0.6799194990967312,0,0,1
298,Base Excision Repair WP4752,0.5874502129011301,1.15543219666931,0.614648079512719,['POLE4'],0.6892749164706593,0,0,1
299,Lipid Metabolism Pathway WP3965,0.5874502129011301,1.15543219666931,0.614648079512719,['HILPDA'],0.6892749164706593,0,0,1
300,Neural Crest Cell Migration during Development WP4564,0.5874502129011301,1.15543219666931,0.614648079512719,['PIK3CD'],0.6892749164706593,0,0,1
301,Development of ureteric collection system WP5053,0.6136701057519496,1.0727172312223858,0.5238054450133666,['SMAD1'],0.7112748859554011,0,0,1
302,miRNA regulation of prostate cancer signaling pathways WP3981,0.6136701057519496,1.0727172312223858,0.5238054450133666,['CDKN1A'],0.7112748859554011,0,0,1
303,PDGFR-beta pathway WP3972,0.6136701057519496,1.0727172312223858,0.5238054450133666,['SHC1'],0.7112748859554011,0,0,1
304,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6163035233420379,0.947941096263976,0.4588183771567557,"['CEBPB', 'CAV3', 'HES5']",0.7112748859554011,0,0,3
305,Chemokine signaling pathway WP3929,0.6163035233420379,0.947941096263976,0.4588183771567557,"['GRK5', 'SHC1', 'PIK3CD']",0.7112748859554011,0,0,3
306,CAMKK2  Pathway WP4874,0.6261499125138884,1.0356381087806612,0.484849991272678,['ICAM1'],0.7132840427342677,0,0,1
307,DNA Replication WP466,0.6261499125138884,1.0356381087806612,0.484849991272678,['CDC7'],0.7132840427342677,0,0,1
308,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6261499125138884,1.0356381087806612,0.484849991272678,['TNFRSF1A'],0.7132840427342677,0,0,1
309,Neural Crest Cell Migration in Cancer WP4565,0.6261499125138884,1.0356381087806612,0.484849991272678,['PIK3CD'],0.7132840427342677,0,0,1
310,Leptin signaling pathway WP2034,0.6327067793973081,0.9381459948320413,0.4294346290826135,"['SOCS3', 'SHC1']",0.7154653115629234,0,0,2
311,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6382275790646532,1.0010309278350515,0.4495233010610209,['HGF'],0.7154653115629234,0,0,1
312,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6382275790646532,1.0010309278350515,0.4495233010610209,['MAP3K14'],0.7154653115629234,0,0,1
313,Vitamin D-sensitive calcium signaling in depression WP4698,0.6382275790646532,1.0010309278350515,0.4495233010610209,['CALB1'],0.7154653115629234,0,0,1
314,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6382275790646532,1.0010309278350515,0.4495233010610209,['SHC1'],0.7154653115629234,0,0,1
315,Pathways Regulating Hippo Signaling WP4540,0.6408795619250927,0.9236334724706817,0.4109372139695183,"['PRKCQ', 'FGFR3']",0.7161574787226432,0,0,2
316,Amyotrophic lateral sclerosis (ALS) WP2447,0.6499160312963934,0.9686564682407716,0.4174057997451668,['TNFRSF1A'],0.7194039088563852,0,0,1
317,IL-5 signaling pathway WP127,0.6499160312963934,0.9686564682407716,0.4174057997451668,['SHC1'],0.7194039088563852,0,0,1
318,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6499160312963934,0.9686564682407716,0.4174057997451668,['ACTN2'],0.7194039088563852,0,0,1
319,B Cell Receptor Signaling Pathway WP23,0.6567949322007177,0.895908056616144,0.37662490786829406,"['BCL6', 'SHC1']",0.7247392355318264,0,0,2
320,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6612277806767929,0.9383054123711341,0.38813650661015997,['HSPB1'],0.7250846691533679,0,0,1
321,Integrated Cancer Pathway WP1971,0.6612277806767929,0.9383054123711341,0.38813650661015997,['CDKN1A'],0.7250846691533679,0,0,1
322,Hippo-Merlin Signaling Dysregulation WP4541,0.6645391124252135,0.88265693874449,0.3607079461989966,"['FGFR3', 'CD44']",0.7264526943281837,0,0,2
323,G13 Signaling Pathway WP524,0.6721749376082943,0.9097938144329897,0.3614034456854823,['PIK3CD'],0.7302641297472826,0,0,1
324,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6721749376082943,0.9097938144329897,0.3614034456854823,['ACTA2'],0.7302641297472826,0,0,1
325,PDGF Pathway WP2526,0.6930219858005191,0.8576583210603829,0.3144977785136392,['SHC1'],0.7494742549007806,0,0,1
326,22q11.2 copy number variation syndrome WP4657,0.694115361072882,0.8333333333333334,0.30426425496633086,"['ACTA2', 'AIFM3']",0.7494742549007806,0,0,2
327,Integrin-mediated Cell Adhesion WP185,0.7011650162042168,0.8218470142649817,0.29176556743471677,"['CAV3', 'SHC1']",0.754379147115065,0,0,2
328,Netrin-UNC5B signaling pathway WP4747,0.7029442052663105,0.8337628865979382,0.29388287208863323,['ICAM1'],0.754379147115065,0,0,1
329,Androgen receptor signaling pathway WP138,0.7148599907112083,0.7997932816537467,0.26846546926772397,"['CDKN1A', 'LIMK2']",0.7648350052594083,0,0,2
330,ATM Signaling Network in Development and Disease  WP3878,0.7218391955551157,0.7897449810092241,0.25741965555316504,['HSPB1'],0.7676356399861048,0,0,1
331,Phosphodiesterases in neuronal function WP4222,0.7218391955551157,0.7897449810092241,0.25741965555316504,['PDE8B'],0.7676356399861048,0,0,1
332,Hepatitis B infection WP4666,0.7270865002942072,0.7957036086019533,0.25359855864788217,"['CDKN1A', 'IRF7', 'PIK3CD']",0.7708868918781956,0,0,3
333,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.730832214132281,0.7694290245836638,0.24127091705667011,['PIM1'],0.7725313494731619,0,0,1
334,Regulation of toll-like receptor signaling pathway WP1449,0.7344129146962662,0.768833233949513,0.23732640609228597,"['IRF7', 'PIK3CD']",0.7739920538116339,0,0,2
335,Eukaryotic Transcription Initiation WP405,0.7395352071262931,0.7501288659793814,0.2263389246174252,['POLR2I'],0.7747511693704023,0,0,1
336,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.7395352071262931,0.7501288659793814,0.2263389246174252,['CP'],0.7747511693704023,0,0,1
337,Nucleotide Excision Repair WP4753,0.7479575045899078,0.7317701785265275,0.21251272968567672,['POLE4'],0.7812493816488059,0,0,1
338,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7561081371707021,0.7142857142857143,0.19969348174718735,['PIK3CD'],0.7851034344663338,0,0,1
339,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7561081371707021,0.7142857142857143,0.19969348174718735,['IRF7'],0.7851034344663338,0,0,1
340,Mesodermal commitment pathway WP2857,0.8291373720821867,0.6237080103359173,0.1168638140049582,"['SMAD1', 'FZD4']",0.8584010440380287,0,0,2
341,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8605837410354102,0.5077319587628866,0.07623308560710602,['LDLR'],0.8883445068752621,0,0,1
342,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8736964745008637,0.48303957432657135,0.06522108863007642,['PRKCQ'],0.8966214548813529,0,0,1
343,DNA IR-damage and cellular response via ATR WP4016,0.8736964745008637,0.48303957432657135,0.06522108863007642,['BCL6'],0.8966214548813529,0,0,1
344,Alzheimer's disease WP2059,0.8777880283373396,0.47533136966126655,0.061959510619176754,['TNFRSF1A'],0.8982017034149522,0,0,1
345,Pathways in clear cell renal cell carcinoma WP4018,0.8997052568846711,0.43377409233527564,0.04584474301096114,['ENPP3'],0.9179601461547948,0,0,1
346,Male infertility WP4673,0.912091591215264,0.40986442592854117,0.03771361981452308,['SOD2'],0.9279082084039679,0,0,1
347,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9194847069528844,0.4778087855297158,0.040108161522763135,"['SHC1', 'IRS2']",0.9327337661308799,0,0,2
348,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9408204040626533,0.3516373559733172,0.02145093857791262,['COX7A1'],0.9516344316955575,0,0,1
349,Ciliopathies WP4803,0.9602713276757128,0.39464722692814486,0.0159987623666878,"['DNAH11', 'SPAG1']",0.9685258090024381,0,0,2
350,DNA Repair Pathways Full Network WP4946,0.9651052756683647,0.29552414004287025,0.0104964528958246,['POLE4'],0.9706201629578982,0,0,1
351,Fragile X Syndrome  WP4549,0.9749260343445209,0.26866815268877126,0.006822471234430483,['SHC1'],0.9777036013939355,0,0,1
352,Ciliary landscape WP4352,0.988868228291647,0.30285292411538256,0.003390194251295432,"['CDH23', 'MAPRE2']",0.988868228291647,0,0,2
